MesemCart – First Patient Treated at University Hospital Dresden
An important milestone in the development of a novel, stem-cell–based therapy for the regeneration of cartilage damage has been reached: At the University Hospital Dresden, the first patient has been successfully treated under the supervision of Prof. Dr. Jörg Lützner as part of the clinical trial “MesemCart.” The Phase I/IIa study, initiated by BIONCaRT GmbH, […]
EMA Approves First-in-Human Study for MesemCart
BIONCaRT GmbH has received approval from the responsible federal authority, the Paul Ehrlich Institute, to conduct a Phase I/IIa clinical trial. The aim of the study is to investigate the safety and initial evidence of efficacy of umbilical cord tissue-derived mesenchymal stromal cells for the treatment of cartilage damage in the knee joint. The clinical […]